two promising novel recombinant tissue-type plasminogen activator ( rt-pa ) regimens for pulmonary embolism ( pe ) are being actively investigated : 100 mg/2 h as a continuous peripheral intravenous infusion , and bolus rt-pa , adjusted to weight , as a 2-min infusion .
C0034065
pulmonary embolism
C0032143
rt-pa